Individual #00025058

ID_report -
Reference PubMed: Krawitz 2012
Remarks Index case with hyperphosphatasia with mental retardation syndrome 2.
Gender F
Consanguinity no
Country -
Population white
Age at death 01y10m (1 year, 10 months)
VIP -
Data_av -
Treatment -
Panel size 1
Diseases HPMRS2
Owner name Philippe Campeau
Database submission license Creative Commons Attribution-NonCommercial-ShareAlike 4.0 InternationalCreative Commons License
Created by Philippe Campeau
Date created 2014-12-03 21:06:45 +01:00 (CET)
Date last edited 2023-02-23 09:56:23 +01:00 (CET)


Phenotypes

hyperphosphatasia, with mental retardation syndrome, type 2 (HPMRS-2, glycosylphosphatidylinositol deficiency, type 6 (GPIBD-6)) (HPMRS2;GPIBD6)   Add phenotype for this disease

AscendingPhenotype ID     

Phenotype details     

Diagnosis/Initial     

Diagnosis/Definite     

Inheritance     

Age/Examination     

Age/Diagnosis     

Age/Onset     

Phenotype/Onset     

Protein     

Owner     
0000021172 She was born with anal atresia and perineal fistula. Additional malformations included an atrial septal defect, peripheral pulmonary stenosis, left coronal synostosis resulting in plagiocephaly, and an enlarged supratentorial ventricular system. Growth development was delayed. Psychomotor development was severely retarded. She developed tonic-clonic seizures at the age of 21 months and died at the age of 22 months as a result of a convulsive crisis. Facial signs included wide-set eyes that appeared large because of long palpebral fissures, a short nose with a broad nasal bridge and nasal tip, and a tented mouth. - - Familial, autosomal recessive - - - - - Philippe Campeau



Screenings


AscendingScreening ID     

Template     

Technique     

Tissue     

Remarks     

Genes screened     

Variants found     

Owner     
0000025062 DNA SEQ-NG - - PIGO 2 Philippe Campeau
0000037981 DNA SEQ - - PIGO Not yet submitted Philippe Campeau



Variants

2 entries on 1 page. Showing entries 1 - 2.
Legend   How to query  

Chr     

Allele     

Effect     

Classification method     

Clinical classification     

AscendingDNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Owner     

Gene     

IDbase Accession Number     

VariO/DNA     

VariO/Protein     

VariO/RNA     

Exon     

DNA change (cDNA)     

Haplotype     

RNA change     

Protein     

P-domain     

Exon_old     

Function/GVS     

Predict/AGVGD     

Predict/MutationTaster     

Predict/SIFT     

Predicted     

Type/DNA     

CpG     

Enzyme activity     

mRNA level     

Predict-BioInf     

Legacy protein change     

Protein level     
9 Maternal (confirmed) +/. - pathogenic g.35090058C>T g.35090061C>T - - PIGO_000003 variant results in aberrant splicing; according to data from the NHLBI Exome Sequencing Project, there is one heterozygous individual for this intronic mutation out of 5,379 tested individuals, which is consistent with the expected incidence of the disease. PubMed: Krawitz et al. 2012 - - Germline yes - - - - Philippe Campeau PIGO - - - - 9i NM_032634.3:c.3069+5G>A - r.2855_3069del p.Val952Aspfs - - - - - - - - - - - - - -
9 Unknown +?/+? - likely pathogenic g.35090263G>A g.35090266G>A - - PIGO_000001 - - - - Germline - - - - - Philippe Campeau PIGO - - - - - NM_032634.3:c.2869C>T - r.(?) p.(Leu957Phe) - - - - - - - - - - - - - -
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.